Board paper to fund CGMs and insulin pumps

Proactive release

At its August 2024 meeting, the Pharmac Board considered a proposal to fund continuous glucose monitors (CGMs) and insulin pumps.

We are releasing the documents the Board used to make its decision. We have withheld some information to protect Pharmac's ability to negotiate with suppliers and people's privacy.

Board paper downloads

Memorandum to the Board | Proposal to fund continuous glucose monitors, insulin pumps and insulin pump consumables for people with type 1 diabetes [PDF, 553 KB]

Appendix 1 | Resolutions [PDF, 274 KB]

Appendix 2 | Individual Budget Impact Analysis (withheld in full under section 9(2)(j) of the Act)

Appendix 3 | Key components of the proposal [PDF, 104 KB]

Appendix 4 | Diabetes Advisory Committee record [PDF, 253 KB]

Appendix 5 | Summary of technical and consumer evaluation committee [PDF, 735 KB]

Appendix 6 | Implementation plan [PDF, 1 MB]

Appendix 7 | Factors for consideration [PDF, 505 KB]

Appendix 8 | All feedback received in response to the consultation (withheld in full under section 9(2)(a) of the Act)

Appendix 9 | Summary of consultation feedback (published in the Decision)